# Effect of Nifedipine GITS in Patients With Mild-to-moderate Primary Hypertension

Study · id `cardio:ct-nct02641821` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02641821](<https://clinicaltrials.gov/study/NCT02641821>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02641821

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 700 participants.

## Technical summary

Registry record NCT02641821. Allocation not applicable; no masking; primary purpose treatment. Start 2015-10 (registry gives no type); primary completion 2019-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 700 participants (planned count; ClinicalTrials.gov record NCT02641821, source copy `cardio:ctgov-nct02641821-2019-03-22`, retrieved 2026-10-26)
- Start date: 2015-10 (registry gives no type) (ClinicalTrials.gov record NCT02641821, source copy `cardio:ctgov-nct02641821-2019-03-22`, retrieved 2026-10-26)
- Primary completion: 2019-12 (anticipated) (ClinicalTrials.gov record NCT02641821, source copy `cardio:ctgov-nct02641821-2019-03-22`, retrieved 2026-10-26)
- Completion: 2019-12 (anticipated) (ClinicalTrials.gov record NCT02641821, source copy `cardio:ctgov-nct02641821-2019-03-22`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT02641821, source copy `cardio:ctgov-nct02641821-2019-03-22`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02641821-2019-03-22`, retrieved 2026-10-26)

## The registry's words

- Brief title: Effect of Nifedipine GITS in Patients With Mild-to-moderate Primary Hypertension
- Condition: Hypertension
- Intervention (Drug): Nifedipine GITS
- Lead sponsor: Peking University First Hospital
- Lead sponsor class: OTHER
- Collaborator: Bayer
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: Peking University First Hospital (`cardio:org-peking-university-first-hospital`)
- Registry lists this organization as a collaborator: Bayer (`cardio:bayer`)

## Provenance

Content hash: 19d76cf4fbac45357d03ff1e0784180c6c5d31742b2938b8fe0d9200a0736db2
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
